🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06655051
Recruiting Not applicable

Single Plastic Stent Vs. Fully Covered Self-Expanding Metal Stent on Benign Biliary Stricture Secondary to Chronic Pancreatitis

NCT06655051 · tracked via the Priya Life Science China tracker
Sponsor
Changhai Hospital
Phase
Not applicable
Started
2025-04-30
Last updated
2025-05-18

Condition(s) studied

Chronic PancreatitisBenign Biliary Stricture

Investigational drug(s) / intervention(s)

endoscopic retrograde biliary drainage (single plastic stent)endoscopic retrograde biliary drainage ( fully covered self-expanding metal stent)

endoscopic retrograde biliary drainage (single plastic stent): Participants will undergo ERCP. A flexible tube is inserted into the duodenum, crossing the sphincter of Oddi to access the biliary system. And the location, diameter, and length of biliary stricture will be evaluated by injection of contrast media. A single plastic stent is then placed across the biliary stricture, allowing the bile duct to resume drainage. The participants will be observed closely after ERCP and record complications. Imaging evaluation will be conducted 6 months after stenting to confirm spontaneous passage of the biliary duct stent, and the stent will be removed via ERCP if it is still in place.

endoscopic retrograde biliary drainage ( fully covered self-expanding metal stent): Participants will undergo ERCP. A flexible tube is inserted into the duodenum, crossing the sphincter of Oddi to access the biliary system. And the location, diameter, and length of biliary stricture will be evaluated by injection of contrast media. A fully covered self-expanding metal stent is then placed across the biliary stricture, allowing the bile duct to resume drainage. The participants will be observed closely after ERCP and record complications. Imaging evaluation will be conducted 6 months after stenting to confirm spontaneous passage of the biliary duct stent, and the stent will be removed via ERCP if it is still in place.

Study summary

The goal of this clinical trial is to compare the efficacy and safety of a single plastic stent versus a fully covered self-expanded metal stent in relieving benign biliary stricture secondary to chronic pancreatitis. The main questions it aims to answer is:

Whether the efficacy of a single plastic stent is non-inferior to that of a fully covered metal stent in patients with benign biliary stricture secondary to chronic pancreatitis?

Participants will be randomly assigned to receive either a single plastic stent (SPS) placement or fully covered self-expanded metal stent placement treatment for 6 months, and they will be followed up for 18 months.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Age 18 or older; 2. Patients diagnosed with CP; 3. Symptomatic biliary stricture documented at time of enrollment for naïve stricture or at the time of prior plastic stent placement in strictures that had 1 prior plastic stent inserted: cholangitis, and/or an increase in total bilirubin or alkaline phosphatase levels(\> 2 times the upper limit of normal) for more than 4 weeks; 4. Confirmation of bile duct stricture by imaging assessment. Exclusion Criteria: 1. Prior plastic stenting exceeding six months or any metal stenting; 2. Incomplete removal of stones from the main pancreatic duct located in the head of the pancreas during ERCP procedures; 3. Biliary stricture of benign etiology other than chronic pancreatitis; 4. Developing obstructive biliary symptoms associated with an attack of acute pancreatitis; 5. Stricture within 2 cm of common bile duct bifurcation; 6. Biliary stricture of malignant etiology; 7. Patients with acute or chronic hepatitis, cirrhosis, primary sclerosing cholangitis, congenital biliary malformations or biliary fistula; 8. Symptomatic duodenal stenosis (with gastric stasis); 9. Subjects for whom endoscopic techniques are contraindicated; 10. Pregnancy, incarceration; 11. Life expectancy \< 1 year; 12. Other conditions that inappropriate to participant in the study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shanghai Changhai Hospital Clinical Research Ward Shanghai Shanghai Municipality Recruiting

More Changhai Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06655051 on ClinicalTrials.gov ↗ ← All trials in China